BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 11502595)

  • 1. Interaction of cations, anions, and weak base quinine with rat renal cation transporter rOCT2 compared with rOCT1.
    Arndt P; Volk C; Gorboulev V; Budiman T; Popp C; Ulzheimer-Teuber I; Akhoundova A; Koppatz S; Bamberg E; Nagel G; Koepsell H
    Am J Physiol Renal Physiol; 2001 Sep; 281(3):F454-68. PubMed ID: 11502595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calmodulin-associated post-translational regulation of rat organic cation transporter 2 in the kidney is gender dependent.
    Wilde S; Schlatter E; Koepsell H; Edemir B; Reuter S; Pavenstädt H; Neugebauer U; Schröter R; Brast S; Ciarimboli G
    Cell Mol Life Sci; 2009 May; 66(10):1729-40. PubMed ID: 19330287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Release of non-neuronal acetylcholine from the isolated human placenta is mediated by organic cation transporters.
    Wessler I; Roth E; Deutsch C; Brockerhoff P; Bittinger F; Kirkpatrick CJ; Kilbinger H
    Br J Pharmacol; 2001 Nov; 134(5):951-6. PubMed ID: 11682442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does urine alkalinization increase salicylate elimination? If so, why?
    Proudfoot AT; Krenzelok EP; Brent J; Vale JA
    Toxicol Rev; 2003; 22(3):129-36. PubMed ID: 15181662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intestinal absorption of aspirin. Influence of pH, taurocholate, ascorbate, and ethanol.
    Hollander D; Dadufalza VD; Fairchild PA
    J Lab Clin Med; 1981 Oct; 98(4):591-8. PubMed ID: 7288271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral activated charcoal in the treatment of intoxications. Role of single and repeated doses.
    Neuvonen PJ; Olkkola KT
    Med Toxicol Adverse Drug Exp; 1988; 3(1):33-58. PubMed ID: 3285126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The peristaltic reflex in the rat ileum: evidence for functional mu- and delta-opiate receptors.
    Coupar IM
    J Pharm Pharmacol; 1995 Aug; 47(8):643-6. PubMed ID: 8583364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Organic cation transporters in psychiatric and substance use disorders.
    Honan LE; Fraser-Spears R; Daws LC
    Pharmacol Ther; 2024 Jan; 253():108574. PubMed ID: 38072333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probenecid, an Old Drug with Potential New Uses for Central Nervous System Disorders and Neuroinflammation.
    García-Rodríguez C; Mujica P; Illanes-González J; López A; Vargas C; Sáez JC; González-Jamett A; Ardiles ÁO
    Biomedicines; 2023 May; 11(6):. PubMed ID: 37371611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Active Pharmaceutical Ingredient Uptake by Zebrafish (Danio rerio) Oct2 (slc22a2) Transporter Expressed in Xenopus laevis Oocytes.
    Chang ED; Owen SF; Hogstrand C; Bury NR
    Environ Toxicol Chem; 2022 Dec; 41(12):2993-2998. PubMed ID: 36102855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. General Overview of Organic Cation Transporters in Brain.
    Koepsell H
    Handb Exp Pharmacol; 2021; 266():1-39. PubMed ID: 33782773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional inhibition of Oct leads to HNF4α upregulation.
    Vollmar J; Kim YO; Marquardt JU; Galle PR; Schuppan D; Zimmermann T
    Exp Ther Med; 2021 Apr; 21(4):349. PubMed ID: 33732322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular and cellular physiology of organic cation transporter 2.
    Wright SH
    Am J Physiol Renal Physiol; 2019 Dec; 317(6):F1669-F1679. PubMed ID: 31682169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Organic cation transporter 3: A cellular mechanism underlying rapid, non-genomic glucocorticoid regulation of monoaminergic neurotransmission, physiology, and behavior.
    Gasser PJ; Lowry CA
    Horm Behav; 2018 Aug; 104():173-182. PubMed ID: 29738736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of organic cation transporter 3 (Oct3) leads to enhanced proliferation and hepatocarcinogenesis.
    Vollmar J; Lautem A; Closs E; Schuppan D; Kim YO; Grimm D; Marquardt JU; Fuchs P; Straub BK; Schad A; Gründemann D; Schattenberg JM; Gehrke N; Wörns MA; Baumgart J; Galle PR; Zimmermann T
    Oncotarget; 2017 Dec; 8(70):115667-115680. PubMed ID: 29383190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between Apparent Substrate Affinity and OCT2 Transport Turnover.
    Severance AC; Sandoval PJ; Wright SH
    J Pharmacol Exp Ther; 2017 Sep; 362(3):405-412. PubMed ID: 28615288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal Drug Transporters and Drug Interactions.
    Ivanyuk A; Livio F; Biollaz J; Buclin T
    Clin Pharmacokinet; 2017 Aug; 56(8):825-892. PubMed ID: 28210973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-HT2C receptor desensitization moderates anxiety in 5-HTT deficient mice: from behavioral to cellular evidence.
    Martin CB; Martin VS; Trigo JM; Chevarin C; Maldonado R; Fink LH; Cunningham KA; Hamon M; Lanfumey L; Mongeau R
    Int J Neuropsychopharmacol; 2014 Oct; 18(3):. PubMed ID: 25522398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quinine enhances the behavioral stimulant effect of cocaine in mice.
    Huertas A; Wessinger WD; Kucheryavykh YV; Sanabria P; Eaton MJ; Skatchkov SN; Rojas LV; Maldonado-Martínez G; Inyushin MY
    Pharmacol Biochem Behav; 2015 Feb; 129():26-33. PubMed ID: 25482328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nucleoside transporters and human organic cation transporter 1 determine the cellular handling of DNA-methyltransferase inhibitors.
    Arimany-Nardi C; Errasti-Murugarren E; Minuesa G; Martinez-Picado J; Gorboulev V; Koepsell H; Pastor-Anglada M
    Br J Pharmacol; 2014 Aug; 171(16):3868-80. PubMed ID: 24780098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.